Van Lanschot Kempen Investment Management N.V. Sells 150 Shares of Align Technology, Inc. (NASDAQ:ALGN)

Van Lanschot Kempen Investment Management N.V. decreased its stake in shares of Align Technology, Inc. (NASDAQ:ALGN) by 0.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 18,487 shares of the medical equipment provider’s stock after selling 150 shares during the quarter. Van Lanschot Kempen Investment Management N.V.’s holdings in Align Technology were worth $3,855,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in ALGN. Covestor Ltd raised its stake in shares of Align Technology by 14.6% in the fourth quarter. Covestor Ltd now owns 415 shares of the medical equipment provider’s stock valued at $87,000 after acquiring an additional 53 shares during the last quarter. Picton Mahoney Asset Management raised its stake in shares of Align Technology by 69.9% in the fourth quarter. Picton Mahoney Asset Management now owns 141 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 58 shares during the last quarter. Smartleaf Asset Management LLC lifted its position in shares of Align Technology by 9.1% during the fourth quarter. Smartleaf Asset Management LLC now owns 766 shares of the medical equipment provider’s stock worth $158,000 after purchasing an additional 64 shares in the last quarter. Beech Hill Advisors Inc. grew its stake in shares of Align Technology by 0.6% during the fourth quarter. Beech Hill Advisors Inc. now owns 11,632 shares of the medical equipment provider’s stock valued at $2,425,000 after purchasing an additional 65 shares during the last quarter. Finally, New York Life Investment Management LLC increased its holdings in shares of Align Technology by 0.7% in the fourth quarter. New York Life Investment Management LLC now owns 9,406 shares of the medical equipment provider’s stock valued at $1,961,000 after purchasing an additional 68 shares in the last quarter. 88.43% of the stock is owned by institutional investors and hedge funds.

Align Technology Trading Up 0.5 %

Shares of NASDAQ ALGN opened at $172.22 on Tuesday. The company has a fifty day moving average price of $172.04 and a 200 day moving average price of $203.84. Align Technology, Inc. has a 1-year low of $141.74 and a 1-year high of $327.49. The firm has a market cap of $12.61 billion, a PE ratio of 30.70, a PEG ratio of 2.24 and a beta of 1.73.

Align Technology (NASDAQ:ALGN) last announced its earnings results on Wednesday, February 5th. The medical equipment provider reported $1.96 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.43 by ($0.47). Align Technology had a net margin of 10.54% and a return on equity of 13.84%. Equities research analysts forecast that Align Technology, Inc. will post 7.98 EPS for the current year.

Analysts Set New Price Targets

ALGN has been the topic of several research reports. Wells Fargo & Company began coverage on Align Technology in a research note on Friday, February 14th. They set an “overweight” rating and a $255.00 price target on the stock. Evercore ISI increased their price objective on shares of Align Technology from $240.00 to $260.00 and gave the company an “outperform” rating in a report on Thursday, February 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of Align Technology in a report on Thursday, February 6th. Leerink Partnrs upgraded shares of Align Technology from a “hold” rating to a “strong-buy” rating in a research report on Monday, January 6th. Finally, Jefferies Financial Group decreased their price objective on Align Technology from $285.00 to $260.00 and set a “buy” rating for the company in a research note on Thursday, January 23rd. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $256.90.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.